Saraswathy Nochur

Saraswathy (Sara) Nochur is Chief DE&I Officer at Alnylam Pharmaceuticals in Cambridge, MA where she works with various stakeholders to increase diversity, promote equity, and foster inclusion at Alnylam, and also co-leads initiatives to increase diversity in clinical trials. She previously was Head, of Regulatory Affairs at Alnylam for 14 years, enabling the development and approval of three RNA interference therapeutics for rare diseases.

Sara is on the Board of Marinus, a company developing innovative therapeutics to treat rare seizure disorders. She is on the Advisory Board of WEST and is a host and Chair of the Board of Hospitality Homes, a non-profit organization that provides free/low-cost housing for patients/families who seek medical care in Boston. She has been in the Boston biotechnology industry since 1989. Sara holds a Ph.D. in Biochemical Engineering from MIT.